FI882160A - Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel. - Google Patents

Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel. Download PDF

Info

Publication number
FI882160A
FI882160A FI882160A FI882160A FI882160A FI 882160 A FI882160 A FI 882160A FI 882160 A FI882160 A FI 882160A FI 882160 A FI882160 A FI 882160A FI 882160 A FI882160 A FI 882160A
Authority
FI
Finland
Prior art keywords
deras
indolizinderivat
azaindol
och
anvaendning som
Prior art date
Application number
FI882160A
Other languages
English (en)
Other versions
FI882160A0 (fi
Inventor
Paul Leroy Anderson
Faizulla Gulamhusein Kathawala
Nicholas Andrew Paolella
Sompong Wattanasin
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/945,750 external-priority patent/US4751235A/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI882160A publication Critical patent/FI882160A/fi
Publication of FI882160A0 publication Critical patent/FI882160A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI882160A 1986-09-10 1988-05-09 Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel. FI882160A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90589786A 1986-09-10 1986-09-10
US06/945,750 US4751235A (en) 1986-12-23 1986-12-23 Anti-atherosclerotic indolizine derivatives
PCT/EP1987/000511 WO1988001997A2 (en) 1986-09-10 1987-09-09 Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
FI882160A true FI882160A (fi) 1988-05-09
FI882160A0 FI882160A0 (fi) 1988-05-09

Family

ID=27129444

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882160A FI882160A0 (fi) 1986-09-10 1988-05-09 Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel.

Country Status (12)

Country Link
EP (1) EP0265640A3 (fi)
JP (1) JPH01500834A (fi)
KR (1) KR880701719A (fi)
AU (1) AU606621B2 (fi)
DK (1) DK254488A (fi)
FI (1) FI882160A0 (fi)
HU (1) HU200769B (fi)
IL (1) IL83821A0 (fi)
NZ (1) NZ221717A (fi)
PL (1) PL267646A1 (fi)
PT (1) PT85662B (fi)
WO (1) WO1988001997A2 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352575A3 (de) * 1988-07-28 1991-08-21 Bayer Ag Substituierte anellierte Pyrrole
EP0363934B1 (en) * 1988-10-13 1993-12-29 Sandoz Ag Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof
JPH04270285A (ja) * 1988-11-14 1992-09-25 Nissan Chem Ind Ltd ピラゾロピリミジン系メバロノラクトン類
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
WO1992019240A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
WO1992019239A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
FR2687402B1 (fr) * 1992-02-14 1995-06-30 Lipha Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
EP1535922A4 (en) 2002-07-11 2006-10-04 Takeda Pharmaceutical PYRROLOPYRIDINE DERIVATIVE AND ITS USE
EP1730146B1 (en) 2004-03-30 2011-05-04 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of jak and other protein kinases
CA2636189A1 (en) 2006-01-17 2007-07-26 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of janus kinases
CN101678022A (zh) 2006-12-21 2010-03-24 弗特克斯药品有限公司 可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
ES2604667T3 (es) 2009-06-17 2017-03-08 Vertex Pharmaceuticals Incorporated Inhibidores de la replicación de virus de influenza
KR20140014110A (ko) 2010-12-16 2014-02-05 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
PL3068776T3 (pl) 2013-11-13 2019-10-31 Vertex Pharma Inhibitory replikacji wirusów grypy
SG10201804021TA (en) 2013-11-13 2018-07-30 Vertex Pharma Methods of preparing inhibitors of influenza viruses replication
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤を調製する方法
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent
US4474971A (en) * 1982-09-29 1984-10-02 Sandoz, Inc. (Tetrahydropyran-2-yl)-aldehydes
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
GR81711B (fi) * 1983-01-24 1984-12-12 Sandoz Ag
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
JPS61502467A (ja) * 1984-06-22 1986-10-30 サンド・アクチエンゲゼルシヤフト メバロノラクトンのピラゾ−ル同族体およびその誘導体、それらの製造方法ならびに用途
US4677211A (en) * 1984-06-29 1987-06-30 Sandoz Pharmaceuticals Corp. Preparation of lactones
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs

Also Published As

Publication number Publication date
JPH01500834A (ja) 1989-03-23
KR880701719A (ko) 1988-11-04
HU200769B (en) 1990-08-28
FI882160A0 (fi) 1988-05-09
NZ221717A (en) 1990-08-28
PL267646A1 (en) 1988-07-21
DK254488A (da) 1988-06-24
WO1988001997A2 (en) 1988-03-24
IL83821A0 (en) 1988-02-29
AU606621B2 (en) 1991-02-14
WO1988001997A3 (en) 1988-04-07
PT85662B (pt) 1990-06-29
AU8022187A (en) 1988-04-07
PT85662A (en) 1987-10-01
DK254488D0 (da) 1988-05-09
HUT46914A (en) 1988-12-28
EP0265640A2 (en) 1988-05-04
EP0265640A3 (en) 1988-05-18

Similar Documents

Publication Publication Date Title
FI870614A (fi) Haerdbara blandningar, vilka innehaoller n-sulfonylaminosulfoniumsalter som kationiskt verksamma katalysatorer.
FI870056A (fi) Diarylalkyl-substituerade alkylaminer, foerfaranden foer deras framstaellning, deras anvaendning, samt dessa innehaollande laekemedel.
FI874125A0 (fi) Tvaettmedelskompositioner, vilka innehaoller polyalkylenglykol-iminodiaettiksyra som stoedsubstans.
FI883175A (fi) Displayfoersett elektroniskt maolspel, som sjaelv raeknar poaeng.
FI873897A (fi) Maenniskans erytropoietin som framstaellts medelst rekombinations-dna-teknik.
FI873054A0 (fi) Hydroformylering som utnyttjar litet flyktiga fosfinligander loesliga i organiska aemnen.
FI861396A0 (fi) Braedparkett som isolerar stegljudet.
FI893557A (fi) Polyestrar, som innehaoller en eterbrygga.
FI882160A (fi) Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel.
FI860983A0 (fi) Broms som maetar moment, saerskilt foer hissar.
FI874465A (fi) Uppvaermningsanordning som anvaender mikrovaogsenergi.
FI864835A0 (fi) Kaerllock som foerhindrar inaotdragning.
FI885070A0 (fi) Fotohaerdbar elektrostatisk tryckskiva, som innehaoller elektronacceptor eller -donator.
FI862476A0 (fi) Zinkbaserade maolfaerger, i vilka anvaends en blandning av eteralkoholer som flytande organiskt loesningsmedel.
FI861250A0 (fi) Organiskt ester- och diestertillsatsmedel, som foerhindrar kristallisation av metyltriasetoxisilanet i enkomponents organopolysiloxankompositioner.
FI843139A (fi) Foerfarande foer framstaellning dihydrokarbylkarbonater, deras anvaendning som tillsatsmedel i braenslen samt dessa innehaollande braensleblandningar.
FI881241A0 (fi) Laettkonstruktionskaerna, saerskilt som stoedkaerna i skida.
FI884154A0 (fi) Elmaskin, som innefattar slitskilar.
FI872248A (fi) Lyssatsisolering, saett att framstaella densamma samt i enlighet daermed framstaelld lysladdning.
FI884105A (fi) N-/substituerad-alkyliden/ fusionerad-bicykloalkyliden- och heteroalkylidenkinolinaminer, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
FI860782A0 (fi) Motionsredskap, tillaeggsanordning foer detta samt anvaendning av redskapet.
FI923164A0 (fi) Foereningar anvaendbara som mellan- produkter.
FI865175A0 (fi) Specialmatta som glidyta.
FI861519A0 (fi) Lakutrustning som lossas hydrauliskt.
FI884358A (fi) Handverktyg som utfoer fram- och tillbakagaoende roerelse, speciellt en metallsaog.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: SANDOZ AG